Skip to main content
Caplight Logo









Siloton

Siloton

Private
BristolHealthcare & Life Scienceshttps://siloton.com

Last Round

Early Funding

Jun 2, 2026

Est. Valuation

$3.07M

Total Funding Raised

$2M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Siloton operates in Healthcare & Life Sciences and is based in Bristol. Its latest recorded funding round was a Grant round in October 2024.

Siloton is a healthtech company that develops portable optical coherence tomography (OCT) devices using photonic chip technology for the at-home monitoring of major eye diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Siloton Comparables

Compare Siloton with similar companies based on industry and business-model similarity.

Siloton comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lumedica Vision
84%
Lumedica, Inc.
81%
Theia Imaging
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Siloton Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJun 2, 2026
GrantOct 18, 2024
SeedDec 15, 2023
SeedMar 25, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ben Hunt

Co-founder Chief Commercial Officer

Founding Team

Euan Allen

Chief Technology Officer & Co-Founder

Founding Team

Alasdair Price

CEO Co-Founder

Founding Team

For institutional investors. Book with your work email.

Siloton Investors

Notable investors and investment history

Siloton investors
InvestorRounds
Innovate UKGrant
Evenlode FoundationSeed
Evenlode ImpactSeed
The Francis Crick InstituteSeed
Quantum Exponential GroupSeed
South East AngelsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 17, 2026

    Open roles increased to 5, 2.5x the trailing average.

  • Aug 1, 2026

    Open roles increased to 3, 2.1x the trailing average.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • receives_financingOct 20, 2026

    Siloton secures a $13.4M, two-year Innovate UK contract to advance portable OCT imaging systems, complete clinical trials, and explore UK manufacturing.

  • is_developingOct 19, 2026

    On Oct 19th '26, Siloton is developing a handheld quantum eye scanner in the United Kingdom designed to make advanced eye diagnostics available outside specialist hospitals and improve access to care.

  • is_developingOct 16, 2026

    Siloton is developing an easy-to-use, handheld binocular-style system that uses photonic chip technology for portable OCT retinal imaging and detects and monitors treatable eye diseases in United Kingdom.

  • receives_financingOct 15, 2026

    Siloton is set to receive $11.1M over two years under an Innovate UK contract to develop its OCT technology, including in-clinic and at-home GiraffeOCT systems and trials, on Oct 15th '26.

  • signs_new_clientOct 14, 2026

    On Oct 14th '26 in the United Kingdom, Siloton signs an £8.4m contract with UKRI International to accelerate development of its GiraffeOCT system, with clinical trials at Sunderland Specialist Eye Hospital during the contract.

Book a demo to see all news

For institutional investors. Book with your work email.

Siloton Filings

Explore SEC and related filing metadata, where available.

Siloton filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Siloton's valuation, stock price, and market status.

Is Siloton a public or private company?

Siloton is a private company.

What is the current stock price of Siloton?

Siloton is a private company, so its shares have no public market price. Caplight tracks Siloton's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Siloton worth (valuation)?

Siloton's valuation is estimated at $3.1M based on funding round data.

Can I buy Siloton stock?

Siloton shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Siloton's last funding round?

Siloton's most recent funding round was Early Funding on June 2, 2026.

Who are the main investors in Siloton?

Key investors in Siloton include Evenlode Impact, Quantum Exponential Group, South East Angels.

Will Siloton IPO soon?

No public IPO plans have been announced for Siloton.

How can I track Siloton secondary market activity?

Caplight tracks bids, offers, and trades in Siloton's shares on secondary markets.

Firmographic Details

HeadquartersBristol
Employee Range10
Year Founded2020
Last FundingJun 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?